B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

PIP4K2A

MOLECULAR TARGET

phosphatidylinositol-5-phosphate 4-kinase type 2 alpha

UniProt: P48426NCBI Gene: 530514 compounds

PIP4K2A (phosphatidylinositol-5-phosphate 4-kinase type 2 alpha) is targeted by 14 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting PIP4K2A

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Kaempferols0.691
2Thyroxine0.691
3Luteolin 5,7,3',4'-tetrahydroxy-flavone,0.691
4myricetin-3-O-galactopyranoside [Supplementary Concept]0.691
5Diiodotyrosine0.691
6Disulfiram0.691
7Emodin Purgative anthraquinone found in several plants, especially RHAMNUS PURSHIANA. It was formerly used as0.691
8gamma-Linolenic Acid0.691
9Methyldopa0.691
10Masoprocol0.691
11Oxytetracycline0.691
12piceatannol0.691
13rafoxanide0.691
14Thyroxine0.691

About PIP4K2A as a Drug Target

PIP4K2A (phosphatidylinositol-5-phosphate 4-kinase type 2 alpha) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 14 compounds with documented PIP4K2A interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

PIP4K2A inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.